 |
Table №6
| Form of dysbacteriosis |
Basic group |
Control group |
before treatment |
after treatment |
before treatment |
after treatment |
absolute |
% |
absolute |
% |
absolute |
% |
absolute |
% |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
Reduction of bifido- and lactobacteria |
103 |
100% |
1 |
1% |
5 |
100% |
3 |
60% |
Presence of conditionally pathogenic flora |
12 |
100% |
4 |
33,33% |
2 |
100% |
2 |
100% |
Complex disorders |
31 |
100% |
8 |
25,81% |
3 |
100% |
3 |
100% |
| Disorders in coprogram |
creatorea |
62 |
100% |
12 |
19,35% |
8 |
100% |
7 |
87,5% |
steatorea |
41 |
100% |
9 |
21,95% |
4 |
100% |
3 |
75% |
amilorea |
78 |
100% |
13 |
16,67% |
6 |
100% |
5 |
83,33% |
| Dynamics of basic clinical symptoms |
Pain in a stomach |
126 |
100% |
13 |
10,32% |
10 |
100% |
6 |
60% |
Dyspeptic disorder s |
53 |
100% |
11 |
20,75% |
8 |
100% |
5 |
62,5% |
Stool disorders (constipation, softened stool) |
146 |
100% |
23 |
15,75% |
10 |
100% |
8 |
80% |
Table №6 shows that basing on the dynamics of clinical materials, the character of the coprogram and the research of microflora of intestines better results were achieved in the basic group where phytocomplex "Gepar" was used in comparison with the control group where the patients did not receive phytocomplex "Gepar".
For example:
Out of 103 patients of the basic group with an insufficient quantity of bifido- and lactobacteria after the treatment only in 1 (1%) the given disorder remained.
Out of 5 patients of the control group after the treatment 3 patients (60 %) still had the given disorder.
The efficiency estimation of the phytocomplex application according to the results of the examination of 42 patients with a chronic cholecystitis (without stones), 146 patients with a dyskinesia of intestines and a dysbacteriosis and 17 practically healthy people is presented in Table №7.
Table №7
№ |
Nozologic form, quantity of patients of the basic group |
Significant improvement |
No changes |
Deterioration |
1 |
2 |
3 |
5 |
6 |
1 |
Chronic cholecystitis
(without stones)
42 patients of the basic group
10 patients of the control group
|
absolute quantity 38.
percentage 90.5%
absolute quantity 2
percentage 20%
|
absolute quantity 4
percentage 9.5 %
absolute quantity 8
percentage 80%
|
absolute quantity 0
percentage 0%
absolute quantity 0
percentage 0%
|
2 |
Dyskinesia of intestines and dysbacteriosis
146 patients of the basic group
10 patients of the control group |
absolute quantity 133
percentage 86,6%
absolute quantity 2
percentage 20%
|
absolute quantity 13
percentage 13,4%
absolute quantity 8
percentage 80%
|
absolute quantity 0
percentage 0%
absolute quantity 0
percentage 0%
|
3 |
Practically healthy
17 patients |
absolute quantity 17
percentage 100%
|
absolute quantity 0
percentage 0%
|
absolute quantity 0
percentage 0%
|
Table №7 shows that
At a chronic cholecystitis without stones out of 42 patients of t he basic group
38 (90.5%) showed a significant improvement;
4 (9.5%) showed no changes.
In the control group of 10 patients
2 (20%) showed a significant improvement:
8 (80%) with the application of the traditional therapy showed no changes.
9. Out of 15 patients with adiposity
8 showed a clinical recovery: during the first three months after the therapy the body weight continued to decrease and the index of body weight reached normal parameters;
5 showed a significant improvement, but the index of body weight did not reached normal parameters;
2 showed no changes.
In the control group of 10 patients
2 showed a clinical recovery: during the first three months after the therapy the body weight continued to decrease and the index of body weight reached normal parameters;
3 showed a significant improvement , but the index of body weight did not reached normal parameters;
5 showed no changes.
The results of the observation let us draw the conclusion that the original technique of the treatment and the preventive maintenance of the diseases of digestion organs and the disorder of metabolism with the help of the biologically active additive to food – the phytocomplex "Gepar" – is rather efficient and it can be recommended for a wide application as a means improving a digestion process both for hospital and for out-patient treatment.
The results of the given clinical tests confirm that the application of the herbs of phytocomplex ‘Hepar' together with the traditional medical products leads to the achievement of better results in shorter terms.
We consider that the original technique of the treatment and the preventive maintenance of the diseases of digestion organs and the disorder of metabolism with the help of biologically active addition – phytocomplex "Gepar" – is rather efficient and can be recommended to wide application as a means improving a digestion process.
Phytocomplex "Gepar" is a rather efficient means of the preventive maintenance of the diseases of digestion organs and the disorder of metabolism and can be recommended as a means improving a digestion process as a biologically active addition to food.
|
